TOKYO -- A Hong Kong-based activist hedge fund is pushing Japanese drugmaker Torii Pharmaceutical to ban accepting executives from parent Japan Tobacco, Nikkei learned Friday.
Pharmaceuticals
Don't fill C-suite with Japan Tobacco alumni, Hong Kong fund says
Activist fund seeks higher returns from Torii Pharmaceutical
Japan Tobacco owns a 55% stake in Torii Pharmaceutical.
Read Next
Latest on Pharmaceuticals
